CH458365A - Verfahren zur Herstellung von neuen Picolylamin-Derivaten - Google Patents

Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Info

Publication number
CH458365A
CH458365A CH41465A CH41465A CH458365A CH 458365 A CH458365 A CH 458365A CH 41465 A CH41465 A CH 41465A CH 41465 A CH41465 A CH 41465A CH 458365 A CH458365 A CH 458365A
Authority
CH
Switzerland
Prior art keywords
picolylamine
derivatives
preparation
new
picolylamine derivatives
Prior art date
Application number
CH41465A
Other languages
German (de)
English (en)
Inventor
Hans Dr Suter
Hans Dipl Chem Zutter
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL128191D priority Critical patent/NL128191C/xx
Priority to GB1084150D priority patent/GB1084150A/en
Application filed by Eprova Ag filed Critical Eprova Ag
Priority to CH41465A priority patent/CH458365A/de
Priority to FR45538A priority patent/FR1463438A/fr
Priority to DE19651545772 priority patent/DE1545772B1/de
Priority to US499047A priority patent/US3350400A/en
Priority to ES0321531A priority patent/ES321531A1/es
Priority to BE674919D priority patent/BE674919A/xx
Priority to NL6600250A priority patent/NL6600250A/xx
Priority to FR45417A priority patent/FR5128M/fr
Priority to DK12166AA priority patent/DK114482B/da
Priority to BR176358/66A priority patent/BR6676358D0/pt
Publication of CH458365A publication Critical patent/CH458365A/de
Priority to IT7830644A priority patent/IT7830644A0/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CH41465A 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten CH458365A (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
NL128191D NL128191C (en:Method) 1965-01-12
GB1084150D GB1084150A (en:Method) 1965-01-12
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten
FR45538A FR1463438A (fr) 1965-01-12 1965-01-21 Procédé de préparation de nouvelles picolylamines et produits obtenus
DE19651545772 DE1545772B1 (de) 1965-01-12 1965-10-14 7-(3'-Picolylamino-alkyl)-theophylline und deren nikotinsaure Salze
US499047A US3350400A (en) 1965-01-12 1965-10-20 7-(picolylaminoalkyl)-theophylline and its salts
ES0321531A ES321531A1 (es) 1965-01-12 1966-01-07 Procedimiento para la fabricacion de nuevas 7-(picolilaminoalquilteofilinas).
BE674919D BE674919A (en:Method) 1965-01-12 1966-01-10
NL6600250A NL6600250A (en:Method) 1965-01-12 1966-01-10
FR45417A FR5128M (en:Method) 1965-01-12 1966-01-11
DK12166AA DK114482B (da) 1965-01-12 1966-01-11 Analogifremgangsmåde til fremstilling af 7-(picolylaminoalkyl)-theophylliner eller syreadditionssalte deraf.
BR176358/66A BR6676358D0 (pt) 1965-01-12 1966-01-11 Processo para a obtencao de novos derivados de picolilamina
IT7830644A IT7830644A0 (it) 1965-01-12 1978-12-06 Picolil-ammine e procedimento per la loro preparazione.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Publications (1)

Publication Number Publication Date
CH458365A true CH458365A (de) 1968-08-30

Family

ID=4186481

Family Applications (1)

Application Number Title Priority Date Filing Date
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Country Status (11)

Country Link
US (1) US3350400A (en:Method)
BE (1) BE674919A (en:Method)
BR (1) BR6676358D0 (en:Method)
CH (1) CH458365A (en:Method)
DE (1) DE1545772B1 (en:Method)
DK (1) DK114482B (en:Method)
ES (1) ES321531A1 (en:Method)
FR (2) FR1463438A (en:Method)
GB (1) GB1084150A (en:Method)
IT (1) IT7830644A0 (en:Method)
NL (2) NL6600250A (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
ES3007652T3 (en) 2019-01-18 2025-03-20 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluoromethoxy)-2-pyrimidinyl]amino]cyclopentyl]amino][1(2h),3'-bipyridin]-2-one as pcsk9 inhibitor and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032554A (en) * 1962-05-01 Process for the preparation of new
US3029239A (en) * 1954-04-17 1962-04-10 Chemiewerk Homburg Zweignieder Basic substituted 1-and 7-alkylxanthines or salts thereof
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen
DE1018869B (de) * 1954-12-14 1957-11-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Aminoalkylpurinderivaten
DE1112983B (de) * 1958-11-21 1961-08-24 Sandoz Ag Verfahren zur Herstellung von Theophyllin-Derivaten
CH402872A (de) * 1959-12-18 1965-11-30 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von Theophyllin- oder Theobromin-Derivaten

Also Published As

Publication number Publication date
DE1545772B1 (de) 1969-12-11
GB1084150A (en:Method)
BR6676358D0 (pt) 1973-09-06
DK114482B (da) 1969-07-07
ES321531A1 (es) 1966-11-01
US3350400A (en) 1967-10-31
BE674919A (en:Method) 1966-07-11
FR5128M (en:Method) 1967-06-05
NL6600250A (en:Method) 1966-07-13
FR1463438A (fr) 1966-12-23
IT7830644A0 (it) 1978-12-06
NL128191C (en:Method)

Similar Documents

Publication Publication Date Title
AT289113B (de) Verfahren zur Herstellung von neuen Pyridinderivaten
CH473749A (de) Verfahren zur Herstellung von neuen Piperidinderivaten
CH493468A (de) Verfahren zur Herstellung von neuen 2-Amido-halogen-benzylaminen
CH458365A (de) Verfahren zur Herstellung von neuen Picolylamin-Derivaten
AT268284B (de) Verfahren zur Herstellung von neuen Isochinolinderivaten
CH490405A (de) Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH471124A (de) Verfahren zur Herstellung von neuen Cyclohexanderivaten
CH476735A (de) Verfahren zur Herstellung von neuen 2-Mercaptoimidazolderivaten
CH469656A (de) Verfahren zur Herstellung von neuen 2-Amino-benzylaminen
CH459206A (de) Verfahren zur Herstellung von neuen 7-Amino-carbostyrilen
AT259565B (de) Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten
CH475270A (de) Verfahren zur Herstellung von neuen 5-Nitro-furyl-derivaten
AT265280B (de) Verfahren zur Herstellung von neuen Hexahydropyrimidinderivaten
AT267519B (de) Verfahren zur Herstellung von neuen Benzimidazolderivaten
AT257608B (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT255412B (de) Verfahren zur Herstellung von neuen 3-Nitro-2-oxo-tetrahydroimidazolderivaten
CH486459A (de) Verfahren zur Herstellung von neuen Dihydrochinolinderivaten
AT261634B (de) Verfahren zur Herstellung von neuen Phosphoramidothioaten
CH516506A (de) Verfahren zur Herstellung von neuen N-Phenylisopropylalkylaminen
AT258304B (de) Verfahren zur Herstellung von neuen 2-Azetidinonderivaten
CH451141A (de) Verfahren zur Herstellung von neuen 1-Hydroxy-piperidinderivaten
CH475986A (de) Verfahren zur Herstellung von neuen Tetrahydrochinolinderivaten
AT263769B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT268270B (de) Verfahren zur Herstellung von neuen Benzimidazolderivaten
AT280291B (de) Verfahren zur herstellung von neuen benzodiazepin-derivaten